BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 38117760)

  • 1. The epidemiology and societal costs of myasthenia gravis in Norway: A non-interventional study using national registry data.
    Engebretsen I; Gilhus NE; Kristiansen IS; Sæther EM; Lindberg-Schager I; Arneberg F; Bugge C
    Eur J Neurol; 2024 May; 31(5):e16233. PubMed ID: 38323756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic burden of breast cancer in northern Serbia.
    Milovic M; Tamas T; Crnobrnja V; Paut Kusturica M
    Front Public Health; 2023; 11():1265301. PubMed ID: 38162600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic aspects of hypertension treatment in Poland.
    Krzysztoszek J; Koligat D; Ratajczak P; Bryl W; Cymerys M; Hoffmann K; Wierzejska E; Kleka P
    Arch Med Sci; 2014 Jun; 10(3):607-17. PubMed ID: 25097594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of glaucoma in Rivers State, Nigeria.
    Adio AO; Onua AA
    Clin Ophthalmol; 2012; 6():2023-31. PubMed ID: 23271881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Excess Costs of Depression and the Influence of Sociodemographic and Socioeconomic Factors: Results from the German Health Interview and Examination Survey for Adults (DEGS).
    König H; Rommel A; Thom J; Schmidt C; König HH; Brettschneider C; Konnopka A
    Pharmacoeconomics; 2021 Jun; 39(6):667-680. PubMed ID: 33521892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct and indirect economic burden of lung cancer in Denmark a nationwide study.
    Gouliaev A; Risikesan J; Christensen NL; Rasmussen TR; Hilberg O; Ibsen R; Løkke A
    Eur Clin Respir J; 2021; 8(1):1951963. PubMed ID: 34377377
    [No Abstract]   [Full Text] [Related]  

  • 7. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socioeconomic burden of schizophrenia: a targeted literature review of types of costs and associated drivers across 10 countries.
    Kotzeva A; Mittal D; Desai S; Judge D; Samanta K
    J Med Econ; 2023; 26(1):70-83. PubMed ID: 36503357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Price tag of glaucoma care is minor compared with the total direct and indirect costs of glaucoma: Results from nationwide survey and register data.
    Purola PKM; Taipale J; Väätäinen S; Harju M; Koskinen SVP; Uusitalo HMT
    PLoS One; 2023; 18(12):e0295523. PubMed ID: 38117760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic and social cost of epilepsy in Poland: 5-year analysis.
    Jędrzejczak J; Majkowska-Zwolińska B; Chudzicka-Bator A; Żerda I; Władysiuk M; Godman B
    Eur J Health Econ; 2021 Apr; 22(3):485-497. PubMed ID: 33582892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Direct and Indirect Costs of Breast Cancer in Poland: Estimates for 2017-2019.
    Seweryn M; Banas T; Augustynska J; Lorenc O; Kopel J; Pluta E; Skora T
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of costs with somatic symptom severity in patients with medically unexplained symptoms.
    Konnopka A; Kaufmann C; König HH; Heider D; Wild B; Szecsenyi J; Herzog W; Heinrich S; Schaefert R
    J Psychosom Res; 2013 Oct; 75(4):370-5. PubMed ID: 24119945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of diabetes and its complications in Poland.
    Leśniowska J; Schubert A; Wojna M; Skrzekowska-Baran I; Fedyna M
    Eur J Health Econ; 2014 Jul; 15(6):653-60. PubMed ID: 23820625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force.
    Husereau D; Drummond M; Augustovski F; de Bekker-Grob E; Briggs AH; Carswell C; Caulley L; Chaiyakunapruk N; Greenberg D; Loder E; Mauskopf J; Mullins CD; Petrou S; Pwu RF; Staniszewska S
    Value Health; 2022 Jan; 25(1):10-31. PubMed ID: 35031088
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.